Showing results (51-60 of 2,890) with videos related to
Sort By:
Pageof 289
Pharmacology, Biochemistry, and Behavior|October 1, 1976
Noradrenaline synthesis from L-DOPA in rodents and its relationship to motor activityA Dolphin, P Jenner, C D MarsdenBiochemical Pharmacology|March 1, 1983
Differentiation of dopamine agonists using drug-induced rotation in rats with unilateral or bilateral 6-hydroxydopamine destruction of ascending dopamine pathwaysC Reavill, P Jenner, C D MarsdenBiochemical Pharmacology|June 15, 1983
Alterations in brain 5HT and tryptamine content during indoleamine-induced myoclonus in guinea pigsG Luscombe, P Jenner, C D MarsdenNeuroscience Letters|November 11, 1988
The D1 agonist SKF 38393 inhibits the antiparkinsonian activity of the D2 agonist LY 171555 in the MPTP-treated marmosetM Nomoto, P Jenner, C D MarsdenPsychopharmacology|July 6, 1978
The effect of chronic administration and withdrawal of amphetamine on cerebral dopamine receptor sensitivityP Jenner, C Pycock, C D MarsdenEuropean Journal of Pharmacology|September 17, 1984
Correlation of [3H]5-hydroxytryptamine (5HT) binding to brain stem preparations and the production and prevention of myoclonus in guinea pig by 5HT agonists and antagonistsG Luscombe, P Jenner, C D MarsdenBiochemical Pharmacology|August 1, 1985
Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the ratN M Rupniak, M D Hall, S Mann, et al.Psychopharmacology|January 1, 1984
Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the ratN M Rupniak, S Mann, M D Hall, et al.Journal of Neural Transmission. Supplementum|January 1, 1988
Receptor changes during chronic dopaminergic stimulationP Jenner, S Boyce, C D MarsdenNeuroscience Letters|October 24, 1994
GABAergic modulation of striatal peptide expression in rats and the alterations induced by dopamine antagonist treatmentJ Jolkkonen, P Jenner, C D MarsdenPageof 289